Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00157
Species: Homo sapiens
Position : chr14:23912000-23912961
Year: 2021
Title: Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  33478249
Tissue: heart left ventricle
Tissue Ontology ID: UBERON:0002084
Cell Source: GM03348-derived human iPSC cardiomyocytes
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay; endogenous enhancer perturbation assay; engineered heart tissue functional assay
High Throughput Method: Promoter Capture Hi-C; ATAC-seq; H3K27ac ChIP-seq; H3K4me3 ChIP-seq; cardiac TF ChIP-seq; gnomAD variant filtering; GTEx eQTL analysis
Low Throughput Method: Dual-luciferase reporter assay of the exact 961-bp MYH7-C3 construct in iPSC-CMs and HL-1 cells; CRISPR/Cas9 dual-guide enhancer deletion in GM03348-derived iPSCs; Sanger genotyping; RT-qPCR; SDS-PAGE myosin isoform analysis; cardiac troponin T flow cytometry; engineered heart tissue contractility assay
About Target Gene
Target gene : MYH7
About TF
TF name : TCF21
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 7 found
Enhancer ID Position Tissue Cell Disease
E_00032 chr14:23912000-23912961 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00033 chr14:23912000-23912961 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00155 chr14:23912000-23912961 heart left ventricle cardiac muscle cell NA
E_00156 chr14:23912000-23912961 heart left ventricle cardiac muscle cell NA
E_00158 chr14:23912000-23912961 heart left ventricle cardiac muscle cell NA
E_00410 chr14:23912000-23912961 NA NA NA
E_00411 chr14:23912000-23912961 NA NA NA
Expression of Target Genes for the Enhancer